Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05155878

Prognostic Factors in Periampullary Tumors and Cysts

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pancreas Cancer Bile Duct Cancer Bile Duct Diseases Bile Duct Neoplasms Biliary Tract Diseases Biliary Tract Neoplasms Cysts Digestive System Diseases Digestive System Fistula Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Fistula Neoplasms Neoplasms by Site Pancreas Cyst Pancreas Disease Pancreas Neoplasm Pancreatic Cyst Pancreatic Diseases Pancreatic Fistula Pancreatic Neoplasms Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Periampullary Cancer Surgery Surgery--Complications

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Surgical Clinic at Umeå University Hospital

Umeå, 90185, Sweden

Location status: Recruiting

Location contact

Agneta Karhu

CONTACT

[email protected]

Asif Halimi, MD/PhD

SUB_INVESTIGATOR

Chiara Scandavini, MD

SUB_INVESTIGATOR

Daniel Öhlund, MD/PhD

SUB_INVESTIGATOR

Mikael Öman, MD/PhD

SUB_INVESTIGATOR

Oskar Franklin, MD/PhD

PRINCIPAL_INVESTIGATOR

Oskar Franklin, PhD

CONTACT

[email protected]

+4690785000

Roberto Valente, MD/PhD

SUB_INVESTIGATOR

Stina Lindblad, MD

SUB_INVESTIGATOR

About this study

From november 2021 an onward, study participants will be prospectively enrolled within the observational study. Before that, study participants are retrospectively enrolled. The study has a broad perspective including studies on clinical outcomes and prognostics based on patient and tumor characteristics.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Recommended surgery for tumor or cyst in the pancreas or periampullary region
  • Information avalible in electronic journal files
  • Informed consent (or deceased for retrospective part of the study)

Exclusion criteria

  • No informed consent (and still alive at study initiation)

Treatment and study plan

Primary outcomes

  1. Overall survival

    Time frame: 10 years

    Overall survival

Secondary outcomes

  1. Complications

    Time frame: 10 years

    Clavien-Dindo, Specific procedure related outcomes

  2. Radical resection

    Time frame: 10 years

    Rates of R0 vs R1/2 resections

Study contacts

Contact information is provided by the study sponsor or research team.

Asif Halimi, MD

CONTACT

[email protected]

+4690785000

Oskar Franklin, MD/PhD

CONTACT

[email protected]

+4690785000

Sponsors and collaborators

Lead sponsor

Umeå University

Other

Registry information

Official study title

Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region

Important dates

Study start
2021
Primary completion
2035
Study completion
2040
First posted
Dec 14, 2021
Registry last updated
Jan 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.